BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 20371430)

  • 1. Tumor necrosis factor alpha and its soluble receptors in obese children with NAFLD.
    Lebensztejn DM; Kowalczuk D; Tarasów E; Skiba E; Kaczmarski M
    Adv Med Sci; 2010; 55(1):74-9. PubMed ID: 20371430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum concentration of adiponectin, leptin and resistin in obese children with non-alcoholic fatty liver disease.
    Lebensztejn DM; Wojtkowska M; Skiba E; Werpachowska I; Tobolczyk J; Kaczmarski M
    Adv Med Sci; 2009; 54(2):177-82. PubMed ID: 20022856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased serum concentration of ceramides in obese children with nonalcoholic fatty liver disease.
    Wasilewska N; Bobrus-Chociej A; Harasim-Symbor E; Tarasów E; Wojtkowska M; Chabowski A; Lebensztejn DM
    Lipids Health Dis; 2018 Sep; 17(1):216. PubMed ID: 30208901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum fetuin A concentration is elevated in children with non-alcoholic fatty liver disease.
    Lebensztejn DM; Białokoz-Kalinowska I; Kłusek-Oksiuta M; Tarasów E; Wojtkowska M; Kaczmarski M
    Adv Med Sci; 2014 Mar; 59(1):81-4. PubMed ID: 24797980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors related to non-alcoholic fatty liver disease in obese children.
    Eminoğlu TF; Camurdan OM; Oktar SO; Bideci A; Dalgiç B
    Turk J Gastroenterol; 2008 Jun; 19(2):85-91. PubMed ID: 19110662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of inflammatory and angiogenic factors in patients with non-alcoholic fatty liver disease.
    Coulon S; Francque S; Colle I; Verrijken A; Blomme B; Heindryckx F; De Munter S; Prawitt J; Caron S; Staels B; Van Vlierberghe H; Van Gaal L; Geerts A
    Cytokine; 2012 Aug; 59(2):442-9. PubMed ID: 22658783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Evaluation of serum visfatin concentrations in children with nonalcoholic fatty liver disease].
    Romanowska A; Lebensztejn DM
    Pol Merkur Lekarski; 2010 Jun; 28(168):459-61. PubMed ID: 20642104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemerin as a novel non-invasive serum marker of intrahepatic lipid content in obese children.
    Kłusek-Oksiuta M; Bialokoz-Kalinowska I; Tarasów E; Wojtkowska M; Werpachowska I; Lebensztejn DM
    Ital J Pediatr; 2014 Nov; 40():84. PubMed ID: 25399407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma levels of soluble tumor necrosis factor-alpha receptors are related to total and LDL-cholesterol in lean, but not in obese subjects.
    Straczkowski M; Kowalska I; Nikolajuk A; Adamska A; Karolczuk-Zarachowicz M; Karczewska-Kupczewska M; Kozlowska A; Gorska M
    Cardiovasc Diabetol; 2006 Jun; 5():14. PubMed ID: 16803616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ultrasonographic and biochemical evaluation of visceral obesity in obese women with non-alcoholic fatty liver disease.
    Fenkci S; Rota S; Sabir N; Akdag B
    Eur J Med Res; 2007 Feb; 12(2):68-73. PubMed ID: 17369120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Serum concentrations of tumor necrosis factor TNFalpha and its soluble receptors in obese women with diabetes type 2 and without additional disease].
    Olszanecka-Glinianowicz M; Waluszek-Kończakowska I; Zahorska-Markiewicz B; Janowska J
    Endokrynol Pol; 2005; 56(2):174-8. PubMed ID: 16335686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Severity of non-alcoholic fatty liver disease is associated with high systemic levels of tumor necrosis factor alpha and low serum interleukin 10 in morbidly obese patients.
    Paredes-Turrubiarte G; González-Chávez A; Pérez-Tamayo R; Salazar-Vázquez BY; Hernández VS; Garibay-Nieto N; Fragoso JM; Escobedo G
    Clin Exp Med; 2016 May; 16(2):193-202. PubMed ID: 25894568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatic steatosis in obese Chinese children.
    Chan DF; Li AM; Chu WC; Chan MH; Wong EM; Liu EK; Chan IH; Yin J; Lam CW; Fok TF; Nelson EA
    Int J Obes Relat Metab Disord; 2004 Oct; 28(10):1257-63. PubMed ID: 15278103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liver steatosis in obese prepubertal children: a possible role of insulin resistance.
    D'Adamo E; Impicciatore M; Capanna R; Loredana Marcovecchio M; Masuccio FG; Chiarelli F; Mohn AA
    Obesity (Silver Spring); 2008 Mar; 16(3):677-83. PubMed ID: 18239582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concentrations of tumour necrosis factor-α and its soluble receptors in the serum of teenagers with atherosclerosis risk factors: obesity or obesity combined with hypertension.
    Obuchowicz A; Kniażewska M; Zmudzińska-Kitczak J; Urban K; Gonciarz-Majda A
    J Pediatr Endocrinol Metab; 2014 Nov; 27(11-12):1209-12. PubMed ID: 25153572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Relationship between serum visfatin level and children and adolescent obesity and non-alcoholic fatty liver disease].
    Wen H; Wang HJ; Dong B; Ma J
    Zhonghua Liu Xing Bing Xue Za Zhi; 2012 Mar; 33(3):269-72. PubMed ID: 22613376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-alcoholic fatty liver disease in young adult severely obese non-diabetic patients in South Italy.
    Colicchio P; Tarantino G; del Genio F; Sorrentino P; Saldalamacchia G; Finelli C; Conca P; Contaldo F; Pasanisi F
    Ann Nutr Metab; 2005; 49(5):289-95. PubMed ID: 16088092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum inflammatory markers in overweight children and adolescents with non-alcoholic fatty liver disease.
    Neuman G; Sagi R; Shalitin S; Reif S
    Isr Med Assoc J; 2010 Jul; 12(7):410-5. PubMed ID: 20862821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum adiponectin, leptin, resistin and RBP4 levels in obese and metabolic syndrome children with nonalcoholic fatty liver disease.
    Boyraz M; Cekmez F; Karaoglu A; Cinaz P; Durak M; Bideci A
    Biomark Med; 2013 Oct; 7(5):737-45. PubMed ID: 24044566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytokeratin 18, a marker of cell death, is increased in children with suspected nonalcoholic fatty liver disease.
    Vos MB; Barve S; Joshi-Barve S; Carew JD; Whitington PF; McClain CJ
    J Pediatr Gastroenterol Nutr; 2008 Oct; 47(4):481-5. PubMed ID: 18852641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.